Delivery Order SPE2DB20D1109-SPE2DB24FP87J

Award Date 9/9/24
Potential Completion Date 9/30/24
Potential Value $30K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,553.31, is for the delivery of 4565242920 INGREZZA 40 MG CAPSULE 30S. The contract is a firm fixed-price delivery order with an ultimate completion date of August 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $44,678.76 firm fixed-price contract is for the supply of INGREZZA 80 MG CAPSULE 30S, a specialty medication. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) worth up to $999,999,999 with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of INGREZZA 80 MG CAPSULE 30S. The order has a firm fixed price of $3,714.98 and a completion date of February 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INGREZZA 40 MG CAPSULE 30S, a specialty medication. The contract has a ceiling value of $3,119.55 and an ultimate completion date of August 16, 2022. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INGREZZA 60 MG CAPSULE 30S, a pharmaceutical product. The contract has a ceiling value of $7,828.66 and a period of performance through August 21, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen, through its Corporate Office division, has been awarded this delivery order as part of its extensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 4,565,215,434 units of the pharmaceutical product INGREZZA 40 MG CAPSULE 30S. The contract has a ceiling value of $10,659.93 and is a firm-fixed-price delivery order, with an ultimate completion date of August 9, 2024. The contract is not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of INGREZZA 40 MG CAPSULE 30S, a specialty medication, with a ceiling value of $6,239.10 and a completion date of June 2, 2023. The contract is a firm fixed-price delivery order and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $14,213.24 to AmerisourceBergen Drug Corp for the supply of 4,563,906,336 units of the pharmaceutical product INGREZZA 40 MG CAPSULE 30S. The contract has an ultimate completion date of March 29, 2024. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM.gov). This contract is a task order under a larger...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $17,766.55 firm-fixed-price contract is for the delivery of INGREZZA 40 MG capsules. The contract has a period of performance through July 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $3,553.31, is for the supply of 4,565,296,598 units of the pharmaceutical product INGREZZA 40 MG CAPSULE 30S. The delivery order has an ultimate completion date of August 20, 2024. No set-aside was used for this contract, and it is structured as a firm fixed-price delivery order. AmerisourceBergen is a major supplier of pharmaceuticals and...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP87J
    Delivery Order

This is a $29,785.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 80 mg capsules of the pharmaceutical drug INGREZZA. The contract has an ultimate completion date of September 30, 2024. AmerisourceBergen is a major pharmaceutical distributor to the federal government and holds several Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice for the provision of a wide range of medical commodities, including prescription drugs, medical supplies, and equipment. This specific delivery order is not associated with a set-aside program.

Generated 12/9/24, 2:04 PM